Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach
Research article
[키워드] active site
acute respiratory syndrome
ADME
Adsorption
approach
Benazepril
binding affinity
can be used
coronavirus
COVID-19
distribution
docking
drug
Drug suitability
drug targets
drugs targeting
effective
evaluate
evaluated
Health
identify
in viral
inhibitor
involved
metabolism
Moexipril
molecular
molecular docking
MPro
non-toxic
potential therapeutic agent
predict
protease
Protein
RdRP
Replication
repurposing
RNA virus
RNA-dependent RNA polymerase
spike glycoprotein
structural proteins
survival
therapeutic
therapeutic targets
Trandolapril
Treatment
virus
was used
[DOI] 10.1016/j.procbio.2021.08.015 [Article Type] Research article
[DOI] 10.1016/j.procbio.2021.08.015 [Article Type] Research article